Northwestern Mutual Wealth Management
XERS icon

Northwestern Mutual Wealth Management’s Xeris Biopharma Holdings XERS Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.2K Sell
2,789
-32
-1% -$212 ﹤0.01% 2876
2025
Q4 		$22.1K Sell
2,821
-4,968
-64% -$39.1K ﹤0.01% 2705
2025
Q3 		$63.4K Buy
7,789
+5,000
+179% +$33.2K ﹤0.01% 2229
2025
Q2 		$13K Hold
2,789
– – ﹤0.01% 2713
2025
Q1 		$15.3K Buy
+2,789
New +$11.3K ﹤0.01% 2601
2022
Q1 		– Sell
-100
Closed – – 3440
2021
Q4 		$0 Hold
100
– – ﹤0.01% 3366
2021
Q3 		$0 Buy
+100
New +$290 ﹤0.01% 3242

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northwestern Mutual Wealth Management's XERS Position: Q1 2026 in Review

Northwestern Mutual Wealth Management reduced its Xeris Biopharma Holdings (XERS) stake by 1.1% in Q1 2026, selling an estimated $212 and leaving 2,789 shares worth $16.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2876.

Northwestern Mutual Wealth Management first reported a position in XERS in Q3 2021 and has held it in 7 quarters since. The position peaked at $63.4K in Q3 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Northwestern Mutual Wealth Management held 2,789 shares of Xeris Biopharma Holdings worth $16.2K as of Q1 2026.
  • Northwestern Mutual Wealth Management sold 32 Xeris Biopharma Holdings shares in Q1 2026, an estimated $212.
  • Xeris Biopharma Holdings made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #2876 holding.
  • Northwestern Mutual Wealth Management first reported a position in Xeris Biopharma Holdings in Q3 2021 and has held it in 7 quarters since.
  • Northwestern Mutual Wealth Management's Xeris Biopharma Holdings position peaked at $63.4K in Q3 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.